Industry Reports
The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >
The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >
From The Drug Channels Blog
Tuesday, November 17, 2026
Drug Channels News Roundup, November 2026: MedImpact’s VytlOne Deal, Medicare Drug Negotiation Final Rule, Part D Premium Surprises, 340B Hospital Spending, and a Part D Glossary
By Bryce Platt, PharmD What do you talk about around the Thanksgiving table or while watching the 100th Macy's Thanksgiving Day Parade? more >
Monday, November 16, 2026
The Direct-to-Patient Opportunity: Evolving Pharma’s DTP Strategy for Lasting Patient Engagement
Today's guest post comes from Sahil Naik, Chief Growth Officer at PHIL Inc. Sahil examines how direct-to-patient programs may be able to support affordability and patient engagement throughout the more >